ArticleScientific African2026
Burden of veno-occlusive disease in tigray region of ethiopia: Evidence from community-based survey.
Article in Scientific African, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
27 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatic veno-occlusive disease refers to a toxic liver injury leading to obstruction and significant morbidity and mortality. Pyrrolizidine alkaloids are among the commonest causes of toxins. In the Tigray region of Ethiopia, this disease linked to toxic plant Ageratum conyzoides. Disruption interventions caused by the COVID-19 pandemic and the Tigray war, potentially leading to escalated reports of the disease. Therefore, this study aims to assess the burden and distribution of hepatic veno-occlusive disease in the northwestern zone of the Tigray region of Ethiopia. Methods: A community-based cross-sectional study was conduct from January to February 2025, involving 2845 households and study participants were selected using multistage random sampling techniques. The data was collected from a defined population within a specific community at a point in time using Open Data Kit tool and exported to SPSS version 25.0 for cleaning and analysis. Multivariable logistic regression was used to identify the association of factors with hepatic veno-occlusive disease. Statistical significance was reported using adjusted odds ratio along with a 95% confidence interval, and at p-value of <0.05. Result: Overall, 6.9% (95% CI: 6.0, 7.9) of households were affected, with 180 cases per 10,000 population. About 250 cumulative deaths per 10,000 population and a notable cumulative case fatality rate (CFR) of 58.1% were found since 2002. This showed with considerable differences among the various administrative districts in the zone. The risk was significantly increased among age groups above thirty, having a larger family size, and believing supernatural force was a cause for the disease. Conclusion: Unevenly distributed, high morbidity, mortality, and case fatality rate due to hepatic veno-occlusive disease were found in Tigray region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.